Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Influenza Clinical Trials

A listing of Influenza medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (82) clinical trials

The purpose of this study is to compare the effects of an experimental drug to see if it is better at treating flu infections. This study will include approximately 7 visits to the research center. Qualified participants may receive study medications and all study related care including physical examinations and ...

Phase N/A

Comparison of Three Licensed Influenza Vaccines

This study will evaluate in detail the way that the immune system responds to three different kinds of flu shots that are licensed in the United States.


A Study to Investigate the Efficacy Safety of CT-P27 in Acute Uncomplicated Influenza A Infection

This study is to evaluate the Efficacy and Safety of CT-P27 comparing placebo in Subjects with Acute Uncomplicated Influenza A Infection.


Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)

Cardiovascular disease is a major cause of morbidity and mortality. There is recent evidence that infection due to influenza may precipitate vascular events such as myocardial infarctions and strokes. There is some evidence that influenza vaccination may prevent such events but the data are inconclusive. The investigators propose a randomized ...


Evaluation of Human Immune Responses to Influenza Virus Vaccination in Patients With Lymphoma

PRIMARY OBJECTIVE: I. To determine the seroprotection and seroconversion rates after influenza vaccination in patients with lymphoma receiving active treatment or in follow up observation. SECONDARY OBJECTIVES: I. To characterize influenza-specific plasmablasts and memory B cells after influenza vaccination in patients with lymphoma receiving active treatment or in follow up ...


A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza

Title: An adaptive study of the pharmacokinetics of favipiravir in patients with severe influenza Study Design: An open label, single group assignment, adaptive study to evaluate the pharmacokinetics of favipiravir in adult patients with severe influenza. In the first stage, participants will receive favipiravir 1600mg BID on day 1, followed ...


Influenza Management With Polyherbal Formulation

Influenza is one of the most common epidemics occurring in India during winter months. Most of the commonly used antiviral have limited efficacy and safety in influenza treatment. Flu Care polyherbal consist of antiviral, antitussive and anti-inflammatory herbal medicine. If this Flu care intervention is shown to be effective, there ...

Phase N/A

Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

The overall duration of a patient participation in the trial is 6 days (screening/randomization/therapy onset - day 1; study therapy period - day 1-5; follow-up period - day 6).


Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza

Influenza is responsible for thousands of hospitalizations and deaths each year in the United States and worldwide. One possible new treatment for the flu involves the use of IVIG, a blood product containing antibodies from people who have recovered from the flu or who have had a flu shot. The ...


Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

Abbreviated title Evaluation of immunogenicity, relative efficacy, safety and reactogenicity of Flublok Quadrivalent in healthy children and adolescents aged 3 to17 years. Sponsor Product Identifiers Flublok Quadrivalent of Laboratories Liomont, S.A. de C.V. Flublok Quadrivalent consists of 180 g total recombinant hemagglutinins Study Phase Phase 3 Study Multicentric, binational Participating ...